Somatic mutations in BRCA1 are more commonly associated with basal-like and triple-negative breast cancers, while somatic BRCA2 mutations can lead to various subtypes, including luminal and TNBC. The gene discussed is BRCA1; the disease is triple-negative breast carcinoma.